Eiken Chemical Co., Ltd.

Equities

4549

JP3160700005

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
2,007 ^JPY	-0.89%		+3.72%	+17.44%

Mar. 21	Tranche Update on Eiken Chemical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.	CI
Mar. 19	Eiken Chemical Co., Ltd.'s Equity Buyback announced on January 30, 2024, has closed with 2,500,000 shares, representing 6.74% for ¥4,636.95 million.	CI

Tranche Update on Eiken Chemical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.

March 21, 2024 at 02:00 am EDT

From January 30, 2024 to March 19, 2024, the company has repurchased 2,500,000 shares, representing 6.74% for ¥4,636.95 million. With this, the company has completed the repurchase of 2,500,000 shares, representing 6.74% for ¥4,636.95 million under the buyback announced on January 30, 2024.

Latest news about Eiken Chemical Co., Ltd.

Tranche Update on Eiken Chemical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.	Mar. 21	CI
Eiken Chemical Co., Ltd.'s Equity Buyback announced on January 30, 2024, has closed with 2,500,000 shares, representing 6.74% for ¥4,636.95 million.	Mar. 18	CI
Eiken Chemical Co., Ltd. announces an Equity Buyback for 2,700,000 shares, representing 7.28% for ¥5,400 million.	Jan. 30	CI
Eiken Chemical Co., Ltd. authorizes a Buyback Plan.	Jan. 29	CI
Lucira Health, Inc. Provides Notice of Termination of the Patent License Agreement by and Between the Company and Eiken Chemical Co., Ltd	22-03-14	CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2020	19-07-23	CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2019	19-01-28	CI
Medicinal Genomics Corp. Partners with Eiken Chemical Co., Ltd. for Cannabis Testing to Drive Higher Yield	19-01-03	CI
Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2019	18-04-26	CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2018	18-01-25	CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2017; Announces Dividend for the Six Months Ended September 30, 2017, Payable on December 1, 2017; Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2018; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2018	17-10-23	CI
Eiken Chemical Co., Ltd. Revised Consolidated and Non Consolidated Earnings Guidance for the First Six Months of Fiscal Year Ending September 30, 2017	17-09-13	CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the First Half Year of Fiscal 2018 and Full Year Ending March 2018	17-07-25	CI
Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Consolidated and Non-Consolidated Earnings Guidance for the Fiscal First Half of 2018 and Full Year of 2018; Declares Consolidated Dividend for the Year Ended March 31, 2017, Payable on June 5, 2017; Provides Dividend Guidance for the Fiscal First Half of 2018 and Full Year of 2018	17-04-26	CI
Eiken Chemical Co., Ltd. Revises Consolidated and Non Consolidated Financial Forecast for the Fiscal Year Ending March 31, 2017	17-03-13	CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2016; Provides Earnings and Dividend Guidance for the Full Year Ending March 31, 2017	17-01-25	CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2016; Declares Interim Dividend for the Six Months Ended September 30, 2016, Payable on December 1, 2016; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2017; Provides Earnings Guidance for the Fiscal Full Year Ending March 31, 2017	16-10-24	CI
Meridian Bioscience, Inc. Expands Molecular Test Technology License with Eiken Chemical Co., Ltd	16-09-26	CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Consolidated Earnings Guidance for the First Six Months and for the Full Year for the Year Ending March 31, 2017; Provides Interim and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2017	16-07-25	CI
Eiken Chemical Co., Ltd. Reports Consolidated and Parent Earnings Results for the Year Ended Mar. 30, 2016; Provides Consolidated and Parent Earnings and Dividend Guidance for the Six Months and Full Year of Fiscal 2017	16-04-26	CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2015; Provides Consolidated Earnings Results for the Fiscal Year Ending March 31, 2016; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2016	16-01-25	CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2015; Declares Quarterly Dividend, Payable on December 01, 2015; Provides Dividend Guidance for the Fourth Quarter and Full Year Ending March 31, 2016; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2016	15-10-22	CI
Eiken Chemical Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2015 Provides Second Quarter and Year End Dividend Guidance for Full Year of the Fiscal Year Ending March 31, 2016; Provides Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2016	15-07-23	CI
Eiken Chemical Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Full Year Ended March 31, 2015; Provides Consolidated and Non- Consolidated Earnings Guidance for the First Half of Fiscal Year Ending March 31, 2016 and Full Year Ending March 31, 2016; Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2016 and Full Year Ending March 31, 2016; Announces Dividend for the Year Ended March 31, 2015, Payable on June 4, 2015	15-04-26	CI
Eiken Chemical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2014; Provides Earnings Guidance for the Ending March 31, 2015	15-01-26	CI

Chart Eiken Chemical Co., Ltd.

Duration

Period

More charts

Company Profile

EIKEN CHEMICAL CO., LTD. is a Japan-based company principally engaged in the manufacture and sale of test drugs. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-08 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Eiken Chemical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2,007 JPY

Average target price

1,750 JPY

Spread / Average Target

-12.81%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
EIKEN CHEMICAL CO., LTD.	+17.44%	441M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution